P86 The Screening and Diagnosis of Cystic Fibrosis-Related Diabetes in the United Kingdom

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Thorax

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/THORAXJNL-2012-202678.328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevation of 1-Hour Plasma Glucose During Oral Glucose Tolerance Testing Is Associated With Worse Pulmonary Function in Cystic Fibrosis

  2011cited by this paper
• Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes

  2010cited by this paper
• Oral glucose tolerance testing in children with cystic fibrosis

  2010cited by this paper
• Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.

  2010cited by this paper
• Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system.

  2010cited by this paper
• One‐year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements

  2009cited by this paper
• Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality

  2009cited by this paper
• Diabetes as a Determinant of Mortality in Cystic Fibrosis

  2009cited by this paper
• Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis.

  2008cited by this paper
• Continuous glucose monitoring in adolescents with cystic fibrosis.

  2005cited by this paper
• Standards of care for patients with cystic fibrosis: a European consensus.

  2005influential reference
• Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis.

  2003cited by this paper
• Clinical improvement in cystic fibrosis with early insulin treatment

  2002cited by this paper
• Presence of cystic fibrosis‐related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis

  2001cited by this paper
• Abnormal glucose metabolism in cystic fibrosis.

  1998cited by this paper
• Glucose tolerance in patients with cystic fibrosis: five year prospective study

  1995cited by this paper
• Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis

  1992cited by this paper

• No citing papers are available for this paper.